Table 1. Characteristics of the BC patients (n = 88) .
Variable | Category | No. (%) |
Age (y) | ≤ 50 | 45 (51.1) |
> 50 | 43 (48.9) | |
BMI (kg/m2) | <25 | 46 (52.3) |
25-29.99 | 28 (31.8) | |
≥30 | 14 (15.9) | |
Pathologic grade | I | 21 (23.9) |
II, III | 67 (76.1) | |
Clinical stage | I | 66 (75) |
II | 14 (15.9) | |
III | 8 (9.1) | |
Tumor size (cm) | < 2.5 | 46 (52.3) |
≥ 2.5 | 42 (47.7) | |
Tumor side status | Right side | 34 (38.6) |
Left side | 54 (61.4) | |
Lymph node metastasis | N1 | 64 (72.7) |
N2 | 13 (14.8) | |
N3 | 11 (12.5) | |
Estrogen receptor status | Negative | 43 (48.9) |
Positive | 45 (51.1) | |
Progesterone receptor status | Negative | 58 (65.9) |
Positive | 30 (34.1) | |
Her-2/neu receptor status | Negative | 61 (69.3) |
Positive | 27 (30.7) | |
P53 | Negative | 66 (75) |
Positive | 22 (25) |